NewBridge Pharmaceuticals specializes in providing innovative healthcare products to the Middle East, Africa, Turkey and Caspian Regions. NewBridge’s regional regulatory capabilities and focused sales and marketing expertise provide biotechnology and pharmaceutical companies with a local partner to commercialize cutting-edge FDA and EMEA-approved therapeutic products. NewBridge will initially focus on the licensing and commercialization of high-value products for diseases with sharply rising regional incidence and prevalence such as diabetes, obesity, cardiovascular and oncologic diseases.